Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $23.93 USD
Change Today -0.38 / -1.56%
Volume 92.0K
TRNX On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 5:20 PM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

tornier nv (TRNX) Snapshot

Open
$24.03
Previous Close
$24.31
Day High
$24.32
Day Low
$23.68
52 Week High
10/31/14 - $28.53
52 Week Low
08/24/15 - $21.43
Market Cap
1.2B
Average Volume 10 Days
203.7K
EPS TTM
$-0.43
Shares Outstanding
49.3M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for TORNIER NV (TRNX)

tornier nv (TRNX) Related Businessweek News

No Related Businessweek News Found

tornier nv (TRNX) Details

Tornier N.V., a medical device company, designs, manufactures, markets, and sells orthopaedic products in the United States, France, and internationally. It offers joint implants and bone fixation devices for the shoulder, hand, wrist, elbow, foot, and ankle; sports medicine and biologics products that is used to mechanically repair tissue-to-tissue or tissue-to-bone injuries; and hip and knee joint replacement implants and other ancillary products, including instrumentation. It principally serves surgeons who treat musculoskeletal injuries; and disorders of the shoulder, elbow, hand, wrist, ankle, and foot. The company markets and sells its products through direct sales representatives and independent sales agencies in the United States; and direct sales offices and distributors in approximately 40 countries. Tornier N.V. is headquartered in Amsterdam, the Netherlands.

1,121 Employees
Last Reported Date: 02/24/15

tornier nv (TRNX) Top Compensated Officers

Chief Executive Officer, President and Execut...
Total Annual Compensation: $548.6K
Chief Financial Officer
Total Annual Compensation: $364.4K
Senior Vice President of U.S. Commercial Oper...
Total Annual Compensation: $368.7K
Senior Vice President of International Commer...
Total Annual Compensation: $366.3K
Chief Legal Officer, Senior Vice President an...
Total Annual Compensation: $330.0K
Compensation as of Fiscal Year 2014.

tornier nv (TRNX) Key Developments

Tornier N.V. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 28, 2015

Tornier N.V. reported unaudited consolidated earnings results for the second quarter and six months ended June 28, 2015. Revenue for the second quarter of 2015 was $83.2 million compared to second quarter 2014 revenue of $86.9 million, a decrease of 4.2% as reported and an increase of 4.0% in constant currency. Foreign currency exchange rates negatively impacted second quarter 2015 reported revenue by $7.1 million. Operating loss was $6.94 million as compared to $796 million for the same period last year. Loss before income taxes was $8.79 million as compared to $9.49 million for the same period last year. Consolidated net loss was $9.34 million or $0.19 per basic and diluted share as compared to $10.45 million or $0.21 per basic and diluted share for the same period last year. Net cash provided by operating activities was $4.45 million as compared to net cash used in operating activities of $3.26 million for the same period last year. Purchases of property, plant and equipment was $1.25 million as compared to $3.12 million for the same period last year. Adjusted EBITDA was $8.27 million as compared to $6.07 million for the same period last year. Non-GAAP adjusted net loss was $6.88 million or $0.14 per basic and diluted share as compared to $9.76 million or $0.20 per basic and diluted share for the same period last year. Additions of instruments was $4.6 million as compared to $7.74 million for the same period last year. For the six months, the company reported revenues were $171.31 million as compared to $175.86 million for the same period last year. Operating loss was $10.63 million as compared to $12.98 million for the same period last year. Loss before income taxes was $13.37 million as compared to $15.62 million for the same period last year. Consolidated net loss was $14.46 million or $0.29 per basic and diluted share as compared to $15.69 million or $0.32 per basic and diluted share for the same period last year. Net cash provided by operating activities was $1.61 million as compared to $0.105 million for the same period last year. Purchases of property, plant and equipment was $3.66 million as compared to $4.88 million for the same period last year. Adjusted EBITDA was $18.67 million as compared to $15.59 million for the same period last year. Non-GAAP adjusted net loss was $10.26 million or $0.21 per basic and diluted share as compared to $12.06 million or $0.25 per basic and diluted share for the same period last year. Additions of instruments was $9.28 million as compared to $14.54 million for the same period last year.

Tornier N.V. to Report Q2, 2015 Results on Aug 05, 2015

Tornier N.V. announced that they will report Q2, 2015 results at 5:00 PM, W. Europe Standard Time on Aug 05, 2015

Tornier N.V., Wright Medical Group Inc., Special/Extraordinary Shareholders Meeting, Jun 18, 2015

Tornier N.V., Wright Medical Group Inc., Special/Extraordinary Shareholders Meeting, Jun 18, 2015., at 09:30 Central European Standard Time. Location: Prins Bernhardplein 200. Agenda: To consider shareholder approval of the proposed merger and the issuance of Tornier ordinary shares in connection with the merger in accordance with Dutch law; to consider change in the corporate name to Wright Medical Group N.V.; and to consider the election of new directors effective upon completion of the merger.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TRNX:US $23.93 USD -0.38

TRNX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alphatec Holdings Inc $0.58 USD -0.01
Exactech Inc $18.98 USD +0.16
Orthofix International NV $37.00 USD -0.28
RTI Surgical Inc $6.15 USD +0.05
Wright Medical Group Inc $24.85 USD -0.39
View Industry Companies
 

Industry Analysis

TRNX

Industry Average

Valuation TRNX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 3.5x
Price/Book 2.7x
Price/Cash Flow NM Not Meaningful
TEV/Sales 3.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TORNIER NV, please visit www.tornier.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.